Anthony Banks, one of the co-founders and the vice president of NeuroLux, Inc., will deliver a talk on innovative discovery tools for medical research as one of the guest speakers for Share the Vision 2017 on September 21, 2017, at the EnterpriseWorks Startup Incubator. The event is a startup showcase...
NeuroLux awarded NIH STTR Phase I Grant
NeuroLux, an early stage biotech company based in Champaign, IL, has been awarded a Small Business Technology Transfer (STTR) Phase I grant by the National Institutes of Health (NIH) to develop wireless, battery-free devices for programmable fluid delivery and optogenetic stimulation, in designs fully compatible with the existing NeuroLux HF...
NeuroLux Spinal Optogenetics System Published in PAIN!
This new wireless platform that adapts near-field communication (NFC) technology and microscale LED technologies for optogenetic studies beyond the brain. The reported devices are designed specifically for implantation in a minimally invasive fashion over the mouse spinal cord for wireless and battery-free optogenetic interrogation of spinal circuits in freely moving...
NeuroLux Awarded Direct to Phase II Grant from the National Institutes of Health
NeuroLux is proud to announce that it has been awarded a Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH). The fund, totaling over $1.5M for two years, will support the development of next-generation devices that...